• Go to navigation
  • Go to content
Seloken International

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca Cardiovascular

Main navigation

  • Home
  • The Product
  • Background
  • Ongoing Research
  • Slide Kits
  • Events
  • News
  • Webcasts
  • Press Releases
  • Feedback
  • Toolbox
  • Site map

You are here

  • Home
  • Webcasts

5 September 2005

ESC CONGRESS 2005 Stockholm, Sweden

Sudden cardiac death is a major threat in heart disease
– how to prevent? 

 ESC CONGRESS 2005                                                     View/Listen

Programme

Chairpersons:

Åke Hjalmarson, Sweden
Rainer Dietz, Germany

Definitions and occurrence of sudden cardiac deaths in major trials
John Wikstrand, Sweden

Effects of beta-blockers on sudden cardiac death
Åke Hjalmarson, Sweden

Effects of non-beta-blocking agents including amiodarone on sudden cardiac death
John McMurray, UK

Optimal treatment of today – prophylactic medications and in certain patients combined with intracardiac defibrillator
Michael Bristow, USA

 

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2008